Structural prediction of chimeric immunogens to elicit targeted antibodies against betacoronaviruses

Jamel Simpson1, Peter M Kasson1,2,3

  • 1Program in Biophysics and Department of Biomedical Engineering, Box 800886, Charlottesville VA 22908.

Insights

Scientists designed synthetic coronavirus spike proteins to elicit a broader antibody response. This approach uses computational methods to predict stable protein designs, aiming to improve vaccines against current and future pandemic threats.

Area of Science:

  • Virology
  • Immunology
  • Computational Biology

Background:

  • Betacoronaviruses, including SARS-CoV-2, present a continuous pandemic risk.
  • Spontaneous antibody responses to SARS-CoV-2 are often narrowly focused, limiting effectiveness against variants and future threats.
  • Targeting conserved regions of the viral spike protein could yield broader neutralizing antibodies.

Purpose of the Study:

  • To develop a computational method for designing stable chimeric spike proteins.
  • To create synthetic immunogens that display conserved viral epitopes.
  • To focus the immune response against critical, conserved regions of coronaviruses.

Main Methods:

  • Leveraging AlphaFold for predicting chimeric protein structures.
  • Developing a novel stability scoring metric based on AlphaFold predictions.
  • Evaluating 114 candidate spike chimeras computationally.
  • Validating top candidates using molecular dynamics simulations.
  • Experimental testing of predicted stable and unstable chimeras.

Main Results:

  • The computational approach successfully predicted stable chimeric spike proteins.
  • Molecular dynamics simulations supported the stability of top-ranked designs.
  • Experimental validation confirmed the accuracy of 5 out of 7 predictions for chimera stability.
  • The study demonstrated the feasibility of designing custom immunogens.

Conclusions:

  • The developed design approach is effective for creating stable chimeric spike proteins.
  • This method can be used to engineer immunogens for focused antibody responses.
  • The strategy holds promise for developing next-generation vaccines against coronaviruses.